Singapore, March 18 -- Inspira Technologies, a breakthrough medical technology company based in Israel, has announced the AMAR submission for approval of the INSPIRA ART100, marking a significant milestone in Inspira's venture into new markets.

The company has developed a breakthrough Augmented Respiration Technology (INSPIRA ART), designed to rebalance patient oxygen saturation levels.

AMAR - the Israeli Ministry of Health's medical device regulation unit, is the authority responsible for controlling medical device licenses and approvals including the issuance of certificates of free sale which are necessary for marketing regulatory approvals in the Southeast Asia and South American markets, potentially propelling the company towards t...